Tony Mok Selected Research

Tony Mok Research Topics

Disease

82	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 08/2005
45	Neoplasms (Cancer) 01/2024 - 01/2005
24	Lung Neoplasms (Lung Cancer) 04/2024 - 08/2004
23	Disease Progression 01/2024 - 10/2010
10	Diarrhea 12/2023 - 01/2011
10	Brain Neoplasms (Brain Tumor) 05/2023 - 01/2016
8	Adenocarcinoma of Lung 06/2023 - 08/2005
7	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2005
7	Exanthema (Rash) 06/2023 - 11/2008
7	Adenocarcinoma 12/2018 - 05/2007
6	Dyspnea (Shortness of Breath) 12/2023 - 06/2013
6	Nausea 12/2023 - 09/2013
6	Fatigue 06/2023 - 06/2013
5	Vomiting 12/2023 - 12/2014
5	Cough 06/2023 - 09/2013
5	Acne Vulgaris 06/2023 - 11/2008
5	Stomatitis 06/2023 - 09/2013
4	Pain (Aches) 12/2023 - 09/2013
3	Edema (Dropsy) 05/2023 - 12/2014
3	Peripheral Nervous System Diseases (PNS Diseases) 12/2022 - 11/2020
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 06/2011
3	Vision Disorders (Hemeralopia) 07/2018 - 06/2013
2	Hyperlipidemias (Hyperlipidemia) 03/2024 - 11/2020
2	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2023 - 12/2022
2	Constipation 12/2023 - 12/2022
2	Colorectal Neoplasms (Colorectal Cancer) 12/2018 - 01/2005
2	Neutropenia 02/2015 - 11/2008
2	Hepatocellular Carcinoma (Hepatoma) 02/2014 - 06/2012
2	Alopecia (Baldness) 06/2013 - 11/2008
1	Hemoptysis 12/2023
1	Hypercholesterolemia 05/2023
1	Hypertriglyceridemia 05/2023
1	Genomic Instability 12/2022
1	Weight Gain 12/2021
1	Epilepsy (Aura) 01/2020
1	Chronic Disease (Chronic Diseases) 01/2019
1	Colonic Neoplasms (Colon Cancer) 12/2018

Drug/Important Bio-Agent (IBA)

33	ErbB Receptors (EGF Receptor)IBA 01/2024 - 08/2005
25	Tyrosine Kinase InhibitorsIBA 03/2024 - 12/2009
21	CrizotinibIBA 05/2023 - 05/2013
18	Gefitinib (Iressa)FDA Link 06/2019 - 08/2005
16	PlatinumIBA 01/2024 - 11/2008
16	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019 - 05/2007
14	Biomarkers (Surrogate Marker)IBA 12/2023 - 06/2008
11	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 02/2006
10	Pemetrexed (MTA)FDA Link 06/2023 - 09/2013
9	AfatinibIBA 06/2023 - 09/2013
8	Anaplastic Lymphoma KinaseIBA 03/2024 - 01/2017
8	Cisplatin (Platino)FDA LinkGeneric 06/2023 - 07/2013
8	alectinibIBA 01/2023 - 01/2017
8	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 02/2006
7	Docetaxel (Taxotere)FDA Link 03/2022 - 11/2008
6	lorlatinibIBA 03/2024 - 11/2020
6	Gemcitabine FDA Link 01/2016 - 02/2006
5	osimertinibIBA 01/2024 - 01/2018
5	B7-H1 AntigenIBA 01/2023 - 12/2018
5	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 06/2008
5	ceritinibIBA 12/2022 - 01/2016
4	Phosphotransferases (Kinase)IBA 04/2024 - 05/2007
4	NivolumabIBA 01/2024 - 01/2019
4	Circulating Tumor DNAIBA 12/2022 - 12/2017
4	dacomitinibIBA 10/2022 - 04/2014
4	atezolizumabIBA 01/2022 - 01/2018
3	tremelimumabIBA 12/2023 - 01/2023
3	durvalumabIBA 12/2023 - 01/2023
3	Tumor Biomarkers (Tumor Markers)IBA 01/2023 - 01/2016
3	Cell-Free Nucleic AcidsIBA 01/2022 - 01/2012
3	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 03/2016
2	RNA (Ribonucleic Acid)IBA 04/2024 - 12/2022
2	Immune Checkpoint InhibitorsIBA 12/2023 - 01/2022
2	brigatinibIBA 12/2022 - 05/2021
2	LigandsIBA 01/2018 - 01/2013
2	onartuzumabIBA 02/2017 - 11/2012
2	Bevacizumab (Avastin)FDA Link 10/2014 - 06/2014
1	tyrosine receptor (receptor, tyrosine)IBA 04/2024
1	larotrectinibIBA 04/2024
1	entrectinibIBA 04/2024
1	cyclo(Arg-Pro) (CI 4)IBA 05/2023
1	Creatine Kinase (Creatine Phosphokinase)IBA 12/2022
1	Triglycerides (Triacylglycerol)IBA 12/2021
1	CholesterolIBA 12/2021
1	ensartinibIBA 11/2021
1	pembrolizumabIBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	serum P-component (CIt)IBA 07/2019
1	Imatinib Mesylate (Gleevec)FDA Link 01/2019
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2018
1	Capecitabine (Xeloda)FDA Link 12/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2018
1	cabozantinibIBA 10/2018

Therapy/Procedure

46	Drug Therapy (Chemotherapy) 04/2024 - 08/2005
31	Therapeutics 01/2024 - 08/2004
4	Precision Medicine 10/2021 - 12/2009
3	Immunotherapy 12/2023 - 01/2015
3	Radiotherapy 03/2016 - 10/2010
2	Aftercare (After-Treatment) 01/2022 - 02/2017
2	Chemoradiotherapy 03/2016 - 01/2015
2	Neoadjuvant Therapy 02/2006 - 01/2005
1	Time-to-Treatment 06/2019